Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$39.42 - $48.08 $7.08 Million - $8.64 Million
-179,666 Closed
0 $0
Q1 2021

May 05, 2021

BUY
$32.49 - $45.96 $344,491 - $487,313
10,603 Added 6.27%
179,666 $7.33 Million
Q4 2020

Feb 12, 2021

SELL
$32.59 - $45.26 $512,966 - $712,392
-15,740 Reduced 8.52%
169,063 $7.65 Million
Q3 2020

Nov 12, 2020

BUY
$32.56 - $38.57 $88,400 - $104,717
2,715 Added 1.49%
184,803 $6.54 Million
Q2 2020

Aug 11, 2020

BUY
$27.83 - $37.73 $472,358 - $640,391
16,973 Added 10.28%
182,088 $6.87 Million
Q1 2020

Apr 27, 2020

BUY
$22.38 - $54.06 $24,192 - $58,438
1,081 Added 0.66%
165,115 $4.77 Million
Q4 2019

Feb 10, 2020

BUY
$51.85 - $73.36 $594,719 - $841,439
11,470 Added 7.52%
164,034 $8.51 Million
Q3 2019

Nov 12, 2019

SELL
$40.05 - $57.47 $200,049 - $287,062
-4,995 Reduced 3.17%
152,564 $8.37 Million
Q2 2019

Aug 12, 2019

BUY
$30.3 - $41.14 $3.07 Million - $4.16 Million
101,237 Added 179.75%
157,559 $6.4 Million
Q1 2019

May 15, 2019

SELL
$29.37 - $40.49 $2.02 Million - $2.78 Million
-68,658 Reduced 54.94%
56,322 $1.7 Million
Q4 2018

Feb 13, 2019

SELL
$30.16 - $43.0 $287,666 - $410,134
-9,538 Reduced 7.09%
124,980 $4.2 Million
Q3 2018

Nov 13, 2018

BUY
$32.83 - $42.51 $60,472 - $78,303
1,842 Added 1.39%
134,518 $5.67 Million
Q2 2018

Aug 14, 2018

BUY
$28.77 - $48.27 $183,782 - $308,348
6,388 Added 5.06%
132,676 $0
Q1 2018

May 10, 2018

BUY
$49.22 - $68.43 $336,418 - $467,719
6,835 Added 5.72%
126,288 $6.28 Million
Q4 2017

Feb 14, 2018

BUY
$52.14 - $59.94 $308,616 - $354,784
5,919 Added 5.21%
119,453 $6.44 Million
Q3 2017

Nov 14, 2017

BUY
$51.16 - $58.21 $5.81 Million - $6.61 Million
113,534
113,534 $6.58 Million

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $260M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.